ReviewPharmacy (Basel, Switzerland)2018
The Effectiveness of Nonprescription Drug Labels in the United States: Insights from Recent Research and Opportunities for the Future.
Review in Pharmacy (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Expanding OTC medicine access in non-pharmacy settings for self-medication: a scoping review.Journal of pharmaceutical policy and practice · 2026Review
- Personalized labeling: A strategy for supporting self-medicating patients' decision-making during selection and use.PloS one · 2026Article
- Comprehension and Use of the Over-the-Counter Hearing Aid Product Information Label.Seminars in hearing · 2025Review
- Expanding Pharmaceutical Access Via Over the Counter Drugs.Therapeutic innovation & regulatory science · 2025Article
- Nutrition facts, drug facts, and model facts: putting AI ethics into practice in gun violence research.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Proportion of Over-The-Counter Medicines Containing a Plant Component and Those with Synthetic Substances Administered among Children in a Bulgarian Population.Pharmaceuticals (Basel, Switzerland) · 2024Article
- The Term 'Deselect' is Ambiguous as Used in Research Studies to Support Prescription to Nonprescription Switches.Therapeutic innovation & regulatory science · 2024Article
- Consumer Likelihood to Seek Information on OTC Medicines.Pharmacy (Basel, Switzerland) · 2023Article
- Health literacy characteristics of over-the-counter rapid antigen COVID-19 test materials.Research in social & administrative pharmacy : RSAP · 2022Article
- Identification of undocumented over-the-counter medications in an academic nephrology clinic.Journal of the American Pharmacists Association : JAPhAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite providing a consistent and comprehensible format for over-the-counter (OTC) drug communication, research suggests important limitations in the communication effectiveness of the Drug Facts Label required on OTC drugs in the United States. This literature is reviewed and some of these critical limitations of the Drug Facts Label (DFL) highlighted. These include difficulty communicating complex information that requires integration of multiple pieces of label information and limited adaptability to serve the unique needs of individual populations (e.g., low literacy or older consumers). Potential ways to improve the DFL's communication effectiveness are identified along with complementary opportunities to improve OTC drug communication by leveraging the role of pharmacists and use of adjunctive technologies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.